What they were paid
Summit Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | — | $0 | $672,773 | $0 | $672,773 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Summit Therapeutics Inc. DEF 14A filed April 17, 2026, accession 0001599298-26-000029, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themAudit · Nominating/Governance
The rest of the Summit Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alessandra Cesano | Independent Director | $640,181 |
| Jeff Huber | Independent Director | $649,186 |
| Kenneth A. Clark | Lead Independent Director | $835,697 |
| Mahkam Zanganeh | Director | $0 |
| Manmeet Soni | Director | $0 |
| Mostafa Ronaghi | Independent Director | $625,486 |
| Robert W. Duggan | Chair of the Board | $0 |
| Yu (Michelle) Xia | Director | $649,996 |
The full Summit Therapeutics compensation record
free company briefThis page is one director within Summit Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat